Small-Cap Biotech Could Soar 25% or More

BDSI broke out from a right triangle and double-top on high volume

   
Small-Cap Biotech Could Soar 25% or More

BioDelivery Sciences (BDSI) — This small-cap biopharmaceutical company develops and commercializes therapeutics primarily for pain management and oncology supportive care.

This is a speculative recommendation and not suitable for all investors. It is primarily based on technical analysis since the company is reporting negative earnings. However, in the recently reported second quarter, losses narrowed to $0.05 per share, from $0.36 a year ago. And revenue soared more than 400% year over year to $13.9 million.

On Wednesday, BDSI broke out from a right triangle and double-top on high volume, which was confirmed as it picked up more upside volume and advanced 6% for the day. It also issued a powerful MACD buy signal.

Buy BDSI under $16 with a trading target of $20-plus. A stop-loss order should be placed at $12.75.

08 28 14 bdsi 300x182 Small Cap Biotech Could Soar 25% or More
Click to Enlarge

chart key 300x84 Small Cap Biotech Could Soar 25% or More


Article printed from InvestorPlace Media, http://investorplace.com/2014/08/trade-day-biodelivery-sciences-bdsi/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.